![Frontiers | The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Frontiers | The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma](https://www.frontiersin.org/files/Articles/754687/fonc-11-754687-HTML-r1/image_m/fonc-11-754687-g001.jpg)
Frontiers | The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma
![Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram](https://www.researchgate.net/publication/236100822/figure/tbl2/AS:202838136365068@1425371788588/Comparison-of-the-Normal-CA-19-9-Level-Group-and-Elevated-CA-19-9-Level-Group.png)
Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram
![Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9dd30be94b40d1a5584ba467f720202997d10fdb/4-Table1-1.png)
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-PB15-4535-R1.png/w300)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitnxjed-32.jpg)
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
![CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/c2bd5005-c361-4918-a30a-59237934b956/gr1.gif)
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
![Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Table3-1.png)